SkylineDx

About:

SkylineDx is a pioneer in the field of molecular diagnostics through developing and commercializing innovative, signature-based diagnostics.

Website: http://www.skylinedx.com/

Twitter/X: skylinedx

Top Investors: Van Herk Ventures, Novalis LifeSciences

Description:

SkylineDx is an emerging commercial-stage company focused on the development and commercialization of innovative gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. These tests are designed to accurately determine the type or status of the disease or to predict a patient’s response to a specific treatment.